TXG filings
Corporate insider profile
John R Stuelpnagel Filing Activity
Latest reported as Director of 10x Genomics, Inc. (TXG).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,155,056.00
- Latest transaction
- Aug 11, 2026
Transaction history
